ArticleBMJ open2024

Experiences and perspectives on chimeric antigen receptor (CAR) T-cell therapy among recipients, carers and referrers (RE-TELL): a qualitative study to inform CAR T-cell service design.

Robert Fyfe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.